Monitoring OKT3 treatment: pharmacodynamic and pharmacokinetic measures.
Henell
K R
KR
Laboratory of Immunogenetics and Transplantation, Oregon Health Sciences University, Portland 97201.
Norman
D J
DJ
D015703:Antigens, CD / Q000032:analysis; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods; D005434:Flow Cytometry / Q000379:methods; D006801:Humans; D008212:Lymphocyte Depletion; D008214:Lymphocytes / Q000276:immunology; D015166:Monitoring, Immunologic / Q000379:methods; D016853:Muromonab-CD3 / Q000097:blood* / Q000494:pharmacology / Q000627:therapeutic use*; D016176:T-Lymphocyte Subsets / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology*
D015703:Antigens, CD; D016853:Muromonab-CD3